Biocon Biologics, Viatris to offer Insulin Glargine by Walgreens Prescription Savings Club
Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. have confirmed that Insulin Glargine (insulin glargine-yfgn) injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 percent off the cash price of comparable long-acting insulins purchased at Walgreens.
This decision by Walgreens follows the launch of Insulin Glargine (insulin glargine-yfgn) announced on November 16.
"Biocon Biologics and Viatris co-developed the product, and together the companies are committed to improving patients' access to sustainable, quality and more affordable healthcare," the company said in a .
"The collaboration with Walgreens underscores our efforts to improve outcomes and access for patients by meeting the needs of cash-paying patients and partnering with key stakeholders across the country to lower out-of-pocket costs for insulin users," Biocon added.
Read also: Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.